ES413279A1 - Un procedimiento para la preparacion de compuestos biologi-camente activos en el tratamiento de la hipoglicemia. - Google Patents
Un procedimiento para la preparacion de compuestos biologi-camente activos en el tratamiento de la hipoglicemia.Info
- Publication number
- ES413279A1 ES413279A1 ES413279A ES413279A ES413279A1 ES 413279 A1 ES413279 A1 ES 413279A1 ES 413279 A ES413279 A ES 413279A ES 413279 A ES413279 A ES 413279A ES 413279 A1 ES413279 A1 ES 413279A1
- Authority
- ES
- Spain
- Prior art keywords
- group
- formula
- alk
- carboxylic acid
- pyridyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1528072A GB1437781A (en) | 1972-04-04 | 1972-04-04 | Pyridine derivatives having hypoglycaemic activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES413279A1 true ES413279A1 (es) | 1976-01-01 |
Family
ID=10056262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES413279A Expired ES413279A1 (es) | 1972-04-04 | 1973-04-03 | Un procedimiento para la preparacion de compuestos biologi-camente activos en el tratamiento de la hipoglicemia. |
Country Status (20)
| Country | Link |
|---|---|
| JP (1) | JPS49100091A (ro) |
| AR (1) | AR208269A1 (ro) |
| AT (1) | AT339301B (ro) |
| BE (1) | BE797715A (ro) |
| BG (1) | BG20352A3 (ro) |
| CA (1) | CA999868A (ro) |
| CH (1) | CH576961A5 (ro) |
| CS (1) | CS183689B2 (ro) |
| DD (1) | DD106834A5 (ro) |
| DE (1) | DE2316881A1 (ro) |
| ES (1) | ES413279A1 (ro) |
| FR (1) | FR2182933B1 (ro) |
| GB (1) | GB1437781A (ro) |
| HU (1) | HU165731B (ro) |
| IE (1) | IE37412B1 (ro) |
| IL (1) | IL41825A (ro) |
| NL (1) | NL7304610A (ro) |
| PL (1) | PL96043B1 (ro) |
| RO (2) | RO63069A (ro) |
| ZA (1) | ZA731853B (ro) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4409227A (en) | 1979-08-09 | 1983-10-11 | The Dow Chemical Co. | 4-(((Heterocyclo)thio)methyl)benzoic acids, esters and amides and their pharmaceutical use |
| EP0521549B1 (en) * | 1991-07-03 | 1995-08-23 | Unilever N.V. | Chocolate fillings containing anti-bloom additive |
| ATE121271T1 (de) * | 1991-07-03 | 1995-05-15 | Unilever Nv | Verbesserte schokolade-zusammensetzung. |
| US5453433A (en) * | 1994-05-13 | 1995-09-26 | Sterling Winthrop Inc. | Thiadiazoles and antipicornaviral compositions |
| US6043247A (en) * | 1996-04-19 | 2000-03-28 | Novo Nordisk A/S | Modulators of molecules with phosphotyrosine recognition units |
| JP2000509373A (ja) * | 1996-04-19 | 2000-07-25 | ノボ ノルディスク アクティーゼルスカブ | ホスホチロシン認識ユニットを有する分子のモジュレーター |
| US6329372B1 (en) | 1998-01-27 | 2001-12-11 | Celltech Therapeutics Limited | Phenylalanine derivatives |
| EP1056714B1 (en) | 1998-02-26 | 2004-08-11 | Celltech Therapeutics Limited | Phenylalanine derivatives as inhibitors of alpha4 integrins |
| GB9805655D0 (en) | 1998-03-16 | 1998-05-13 | Celltech Therapeutics Ltd | Chemical compounds |
| US6521626B1 (en) | 1998-03-24 | 2003-02-18 | Celltech R&D Limited | Thiocarboxamide derivatives |
| GB9811159D0 (en) | 1998-05-22 | 1998-07-22 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9811969D0 (en) * | 1998-06-03 | 1998-07-29 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9812088D0 (en) | 1998-06-05 | 1998-08-05 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9814414D0 (en) * | 1998-07-03 | 1998-09-02 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9821061D0 (en) | 1998-09-28 | 1998-11-18 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9821222D0 (en) | 1998-09-30 | 1998-11-25 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9825652D0 (en) | 1998-11-23 | 1999-01-13 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9826174D0 (en) | 1998-11-30 | 1999-01-20 | Celltech Therapeutics Ltd | Chemical compounds |
| US6518283B1 (en) | 1999-05-28 | 2003-02-11 | Celltech R&D Limited | Squaric acid derivatives |
| US6534513B1 (en) | 1999-09-29 | 2003-03-18 | Celltech R&D Limited | Phenylalkanoic acid derivatives |
| US6455539B2 (en) | 1999-12-23 | 2002-09-24 | Celltech R&D Limited | Squaric acid derivates |
| EP1332132B1 (en) | 2000-04-17 | 2007-10-10 | UCB Pharma, S.A. | Enamine derivatives as cell adhesion molecules |
| US6545013B2 (en) | 2000-05-30 | 2003-04-08 | Celltech R&D Limited | 2,7-naphthyridine derivatives |
| US6403608B1 (en) | 2000-05-30 | 2002-06-11 | Celltech R&D, Ltd. | 3-Substituted isoquinolin-1-yl derivatives |
| EP1301488A1 (en) | 2000-07-07 | 2003-04-16 | Celltech R&D Limited | Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists |
| JP2004505110A (ja) | 2000-08-02 | 2004-02-19 | セルテック アール アンド ディ リミテッド | ３位置換イソキノリン−１−イル誘導体 |
| HU230352B1 (hu) * | 2001-06-12 | 2016-02-29 | Wellstat Therapeutics Corporation | Metabolikus rendellenességek kezelésére adható vegyületek és ezeket tartalmazó gyógyászati készítmények |
| GB0405033D0 (en) * | 2004-03-05 | 2004-04-07 | Karobio Ab | Novel pharmaceutical compositions |
| TWI490214B (zh) * | 2008-05-30 | 2015-07-01 | 艾德克 上野股份有限公司 | 苯或噻吩衍生物及該等作為ｖａｐ－１抑制劑之用途 |
| AR074760A1 (es) * | 2008-12-18 | 2011-02-09 | Metabolex Inc | Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico. |
| WO2015000900A2 (en) * | 2013-07-01 | 2015-01-08 | Givaudan Sa | Organic compounds |
| WO2016167153A1 (ja) * | 2015-04-15 | 2016-10-20 | 長谷川香料株式会社 | ピリジン誘導体またはその塩を有効成分とする香味変調剤 |
| EP3440052B1 (en) * | 2016-04-06 | 2023-10-25 | University Of Oulu | Compounds for use in the treatment of cancer |
-
1972
- 1972-04-04 GB GB1528072A patent/GB1437781A/en not_active Expired
-
1973
- 1973-01-01 AR AR247376A patent/AR208269A1/es active
- 1973-03-15 IE IE426/73A patent/IE37412B1/xx unknown
- 1973-03-16 ZA ZA731853A patent/ZA731853B/xx unknown
- 1973-03-19 IL IL41825A patent/IL41825A/en unknown
- 1973-03-30 HU HURO717A patent/HU165731B/hu unknown
- 1973-04-02 AT AT286773A patent/AT339301B/de not_active IP Right Cessation
- 1973-04-03 NL NL7304610A patent/NL7304610A/xx not_active Application Discontinuation
- 1973-04-03 CS CS7300002387A patent/CS183689B2/cs unknown
- 1973-04-03 RO RO7300083382A patent/RO63069A/ro unknown
- 1973-04-03 BE BE129595A patent/BE797715A/xx unknown
- 1973-04-03 CA CA167,818A patent/CA999868A/en not_active Expired
- 1973-04-03 ES ES413279A patent/ES413279A1/es not_active Expired
- 1973-04-03 JP JP48038610A patent/JPS49100091A/ja active Pending
- 1973-04-03 RO RO7300074369A patent/RO62274A/ro unknown
- 1973-04-04 FR FR7312133A patent/FR2182933B1/fr not_active Expired
- 1973-04-04 DD DD169942A patent/DD106834A5/xx unknown
- 1973-04-04 CH CH482673A patent/CH576961A5/xx not_active IP Right Cessation
- 1973-04-04 DE DE2316881A patent/DE2316881A1/de active Pending
- 1973-04-04 BG BG023170A patent/BG20352A3/xx unknown
- 1973-04-04 PL PL1973161704A patent/PL96043B1/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA999868A (en) | 1976-11-16 |
| IL41825A (en) | 1977-03-31 |
| HU165731B (ro) | 1974-10-28 |
| JPS49100091A (ro) | 1974-09-20 |
| BG20352A3 (bg) | 1975-11-05 |
| FR2182933A1 (ro) | 1973-12-14 |
| IL41825A0 (en) | 1973-05-31 |
| FR2182933B1 (ro) | 1976-05-14 |
| RO63069A (fr) | 1978-08-15 |
| CH576961A5 (ro) | 1976-06-30 |
| ZA731853B (en) | 1974-01-30 |
| GB1437781A (en) | 1976-06-03 |
| DD106834A5 (ro) | 1974-07-05 |
| CS183689B2 (en) | 1978-07-31 |
| ATA286773A (de) | 1977-02-15 |
| DE2316881A1 (de) | 1973-10-11 |
| IE37412B1 (en) | 1977-07-20 |
| AR208269A1 (es) | 1976-12-20 |
| PL96043B1 (pl) | 1977-11-30 |
| NL7304610A (ro) | 1973-10-08 |
| BE797715A (fr) | 1973-10-03 |
| AT339301B (de) | 1977-10-10 |
| RO62274A (fr) | 1977-12-15 |
| IE37412L (en) | 1973-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES413279A1 (es) | Un procedimiento para la preparacion de compuestos biologi-camente activos en el tratamiento de la hipoglicemia. | |
| KR880001591A (ko) | 테트라하이드로 나프탈렌 및 인단유도체 | |
| ES471981A1 (es) | Un procedimiento para la preparacion de derivados de imida- zoquinazolina | |
| FR2414039A1 (fr) | Derives de prostacycline, leur procede de preparation et leurs applications en therapeutique | |
| JPS5412372A (en) | Thiazolidine derivative and its preparation | |
| GB1384504A (en) | Bridgeheadheterocyclic compounds their production and their medicinal use | |
| FR2354761A1 (fr) | Acides n-aryl-anthraniliques, leurs procedes de preparation et compositions pharmaceutiques contenant lesdits acides anthraniliques | |
| FR2430418A1 (fr) | Derives halogenomethyles d'a-aminoacides, leur preparation et leurs utilisations therapeutiques | |
| GB1438265A (ro) | ||
| ES472847A1 (es) | Procedimiento para la preparacion de la 2-bromoergosina y sus sales acidas de adicion | |
| ATE67406T1 (de) | Nicorandil enthaltende zubereitung zum einspritzen. | |
| NO811798L (no) | Nye substituerte 3-fenoksy-1-alkoksykarbonyl-alkylaminopropanoler-2 med beta-reseptorblokkerende egenskaper | |
| IE40068B1 (en) | Isoquinoline derivatives and process for preparing them and phamaceutical preparations comprising them | |
| FR2372836A1 (fr) | Derives de l'acide propionique, leurs procedes de preparation et leur application en therapeutique | |
| SE7701187L (sv) | Nya piperazinderivat och sett att framstella desamma | |
| ES475361A1 (es) | Procedimiento para preparar un nuevo derivado de piridina | |
| ES476266A1 (es) | Procedimiento para la preparacion de diaminas ciclicas n,n'-disustituidas. | |
| JPS5283380A (en) | Synthesis of thiocarbostyril derivatives | |
| GB1391862A (en) | Benzodiazepines | |
| FR2390954A1 (fr) | Nouvelles guanylhydrazones, leurs procedes de preparation et medicaments les contenant | |
| FR2368489A1 (fr) | Derives de la clavuline, leur procede de preparation et leur application en therapeutique | |
| JPS5677272A (en) | Monoester compound of kojic acid | |
| FI892685A0 (fi) | Menetelmä uusien, sytostaattisesti vaikuttavien antrasykliinijohdannaisten valmistamiseksi | |
| ES433131A1 (es) | Procedimiento para la obtencion de derivados de 1-fenoxi-3- amino-propan-2-ol. | |
| ES369304A1 (es) | Procedimiento de preparacion de nuevos derivados nitrogena-dos de la metil-2 benzil-3 imidazo-3h (4,5-b) piridina. |